Hikma Pharmaceuticals (HIK) Pharma and Biotech Sector

  • Latest quote

    1,182.00p (mid)

  • Current Change (%)

    2.16%

  • Price

    Bid: 1,181.00p

    Offer: 1,182.00p

  • Today

    High: 1,182.00p

    Low: 1,138.00p

  • This year

    High: 2,297.00p

    Low: 1,119.00p

  • Information

    Volume: 464,976

    Market Cap: £2836.8M


Hikma Pharmaceuticals RNS Feed

Title Release date
Block listing Interim Review 09:49 - October 5, 2017
Total Voting Rights 15:36 - October 2, 2017
Holding(s) in Company 15:29 - September 28, 2017
Holding(s) in Company 11:27 - September 25, 2017
Holding(s) in Company 15:52 - September 14, 2017
Holding(s) in Company 08:41 - August 25, 2017
Half-year Report 07:00 - August 17, 2017
Hikma announces licensing agreement with Takeda 07:00 - August 17, 2017
Director/PDMR Shareholding 10:05 - August 10, 2017
Director/PDMR Shareholding 10:02 - August 10, 2017
Holding(s) in Company 09:56 - August 4, 2017
Notice of Results 14:22 - August 3, 2017
Total Voting Rights 11:02 - July 4, 2017
Holding(s) in Company 15:03 - July 3, 2017
Holding(s) in Company 16:11 - June 30, 2017

NOTE: This is based on 65 open tips for this company


Total Number of Share tips :

65

View all Hikma Pharmaceuticals Tips


Company overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today